Serial Number | 79353016 |
Word Mark | VISCOFAN FIBERCOLL-FLEX |
Filing Date | Thursday, July 28, 2022 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, June 25, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 25, 2024 |
Goods and Services | Hydrogels for medical, veterinary and pharmaceutical purposes for cellular biology applications; hydrogels for cell growth, cell growth and transplantation, assays based on cells, cancer cell research, regenerative medicine, stem cell growth and drug delivery for medical use; hydrogels for cell culture for medical, veterinary and pharmaceutical purposes; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes; cell culture media for medical use; nutritional agents for processing living cells, namely, cell culture media growth factors contained within a reservoir; synthetic peptides for the treatment of degenerated hard and soft tissues; synthetic peptide derivativesfor the treatment of degenerated hard and soft tissues; cells for medical, veterinary and pharmaceutical use; cells or tissues in hydrogels for medical, veterinary or pharmaceutical use; pharmaceutical preparations for use in 3D bio-printing of tissues and organs; pharmaceutical preparations with other materials and ingredients for use in 3D bio-printing of tissues and organs; regenerative tissue being pharmaceutical preparations for hard and soft tissue regeneration; cells for medical use; allogeneic human tissue; living cells for medical use; implants containing living tissue; implantable living tissue materials for use in guided tissue regeneration; skin grafts; surgical implants formed by living tissue; surgical implants of living tissues derived from stem cells; transdermal patches for the creation of skin for prostheses and skin grafts; living tissue for transplants; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular, and nervous tissues and organs, for medical purposes; biological molecules being implants comprising living tissue to assist in tissue engineering, namely, hard and soft tissue regeneration; hemostatic gel matrix preparations for wound treatment; natural biomaterials for the growth of bones, blood and tissues for medical purposes; pharmaceutical products for the regeneration of tissues, for the repair of tissues, for the treatment of tissues, whether human or animal, namely, 3D implants for hard and soft tissue regeneration combining bioinks and biological materials; pharmaceutical preparations for the treatment of diseases of bones, cartilages, blood vessels, nerve cell degeneration, tendon and ligament degeneration, retinal degeneration, kidney degeneration; soft tissue degenerations, for diseases with abnormal cell growth, namely, formulated bioinks for hard and soft tissue regeneration combining bioinks and biological materials with a pharmaceutical effect; natural biomaterial for bone filling; natural biomaterial for cartilage filling; biological tissue cultures for medical use; biological tissue cultures for medical purposes; biological tissue grafts; bone and skin biological tissues impregnated with oxygen lines for tissue constructs applicable for increasing the cell survival in tissue intended for subsequent implants; gene therapy products, namely, genetically modified tissues for the transplant thereof; implantable stents composed primarily of living tissue to maintain the structure of the tissue; natural biomaterial for bone and tissue growth for medical purposes |
Goods and Services | Inks of biological origin for printers; inks of biological origin for 3D printers |
Goods and Services | Biological materials or preparations for 3D printers, namely, bioinks, bioprinting kits comprised of collagen, biological printed tissues other than for medical or veterinary purposes; hydrogels for cell culture not for medical or veterinary purposes; hydrogels for cell growth not for medical or veterinary purposes; cell culture media other than for medical or veterinary use; nutritional agents for processing living cells other than for medical use, namely, cell culture media within a reservoir for growth factors; culture media for microbiology for laboratory use; reagents for scientific and medical research; synthetic peptides not for pharmaceutical purposes, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; synthetic peptide derivatives not for pharmaceutical purposes, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; cells other than for medical, veterinary or pharmaceutical use; cells or tissues in hydrogels other than for medical, veterinary or pharmaceutical use; biologically compatible polymers, specifically hydrogels used to produce polymer networks used in the manufacture of engineered living tissues for medical, scientific and non-scientific purposes, namely, tissue implants, organoids, tissue models; cell culture media for use in the biotechnological industry for laboratory use; cell culture media for use in non-medical research laboratories; biological preparations for use in cell culture, other than for medical and veterinary purposes; engineered living tissues and tissue arrays, namely, human and animal organs, connective tissue, epithelial tissue, muscular tissue and nervous tissue, and tissue arrays, for use in scientific and medical research; biologically compatible materials, specifically, hydrogels used to create polymeric networks used in the manufacture of living tissues for laboratory use; proteins in the form of raw materials for scientific and medical research |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 21, 2022 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 002 - Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood; colorants; mordants; raw natural resins; metals in foil and powder form for painters, decorators, printers and artists. |
US Class Codes | 006, 011, 016 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 21, 2022 |
Primary Code | 002 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 21, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | VISCOFAN, S.A. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 88 - NOT AVAILABLE |
Address | ES |
Party Name | VISCOFAN, S.A. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 88 - NOT AVAILABLE |
Address | ES |
Event Date | Event Description |
Wednesday, March 1, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, October 20, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, October 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 25, 2022 | APPLICATION FILING RECEIPT MAILED |
Thursday, February 23, 2023 | ASSIGNED TO EXAMINER |
Tuesday, February 28, 2023 | NON-FINAL ACTION WRITTEN |
Saturday, April 22, 2023 | REFUSAL PROCESSED BY MPU |
Saturday, April 22, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, May 17, 2023 | REFUSAL PROCESSED BY IB |
Friday, October 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, October 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, October 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 1, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
Wednesday, November 29, 2023 | FINAL REFUSAL WRITTEN |
Wednesday, November 29, 2023 | FINAL REFUSAL E-MAILED |
Wednesday, November 29, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, March 20, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Wednesday, March 20, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Monday, April 8, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Thursday, May 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, June 5, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, June 11, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Tuesday, June 11, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Tuesday, June 25, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, June 25, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Thursday, May 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, May 9, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |